ATLANTA and AUSTIN, Texas – goodblend™ Texas, a retail brand of Parallel, one of the nation’s privately-held multi-state cannabis operators, announced the launch of the first medical marijuana chocolate bar for patients registered in the Texas Compassionate Use Program. The Heights Dark Chocolate bar is the fifth first-to-market product innovation that it has launched in Texas in the last year.
“goodblend is proud to be the first medical cannabis dispensary in Texas to offer medical marijuana chocolate to patients across the Lone Star State,” said Gene Tallman, President of goodblend Texas. “Studies suggest that by infusing THC with lipids like those found in chocolate, the beneficial THC experience may be amplified. This is great news for patients who need long-lasting relief from conditions such as PTSD, cancer, or neurological diseases.”
The chocolate bar recipe was designed in-house by goodblend’s expert chocolatier, and provides patients with a precise dose of 5mg of THC per square. Each child-resistant package contains 20 single-serving squares for 100mg of THC per bar. The new chocolate bar will be available for $35 starting March 15 exclusively at goodblend Texas.
The launch of this new cannabis product format in Texas follows the recent news that Parallel invested $25M in a new state-of-the-art cannabis cultivation, production, and retail facility in San Marcos. This financial commitment expands Parallel’s ability to meet the growing demand for medical cannabis products in Texas. The planned 63,000 square-foot facility is expected to create hundreds of new jobs in the San Marcos region. The company also recently introduced its goodblend™ retail brand, which reflects Parallel’s intent to lead the way to the future of cannabis by providing patients a trusted, consistent and seamless way to connect and learn, and to access innovative, high-quality cannabis products in a variety of formulations.
(This information is primarily sourced from Parallel; goodblend. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).